Showing results (291-300 of 419) with videos related to
Sort By:
Pageof 42
RMD Open|November 2, 2019
Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extensionGerd R Burmester, Vibeke Strand, Andrea Rubbert-Roth, et al.Journal of Biomedical Materials Research. Part B, Applied Biomaterials|November 7, 2024
Additively Manufactured 3D Clamp-Culture System for the Investigation of Material-Cell Interactions in Multi-Material Hybrid Scaffolds for Musculoskeletal Tissue DefectsSimon Enbergs, Lennard K Shopperly, Andreas Engels, et al.Advances in Therapy|August 28, 2025
Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel DiseaseGerd R Burmester, Atul Deodhar, Alan D Irvine, et al.Arthritis Research & Therapy|June 21, 2018
Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritisVibeke Strand, Laure Gossec, Clare W J Proudfoot, et al.Lancet (London, England)|January 9, 2013
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trialGerd R Burmester, Ricardo Blanco, Christina Charles-Schoeman, et al.Rheumatology (Oxford, England)|November 17, 2020
Peripheral blood mononuclear cells are hypomethylated in active rheumatoid arthritis and methylation correlates with disease activityIlka Liebold, Andreas Grützkau, Anika Göckeritz, et al.Arthritis Research & Therapy|August 14, 2015
Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritisLuisa Lindenberg, Lydia Spengler, Holger Bang, et al.International Journal of Molecular Sciences|July 2, 2021
A Novel Method Facilitating the Simple and Low-Cost Preparation of Human Osteochondral Slice Explants for Large-Scale Native Tissue AnalysisJacob Spinnen, Lennard K Shopperly, Carsten Rendenbach, et al.Annals of the Rheumatic Diseases|May 23, 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 yearsGerd R Burmester, Jacques-Eric Gottenberg, Roberto Caporali, et al.Journal of Tissue Engineering and Regenerative Medicine|April 30, 2019
Online measurement of oxygen enables continuous noninvasive evaluation of human-induced pluripotent stem cell (hiPSC) culture in a perfused 3D hollow-fiber bioreactorSelina Greuel, Nora Freyer, Güngör Hanci, et al.Pageof 42